Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Hengli Medicine Science & Technology is a China-based contract research organization (CRO) that provides comprehensive R&D services to the pharmaceutical industry. Founded in 2010 and headquartered in Jinan, the company specializes in chemical synthesis, formulation development, and analytical services for both generic and innovative drugs. Their expertise extends to regulatory affairs, assisting clients with NMPA registrations and consistency evaluations for generic medications. By leveraging an integrated technology platform, Shandong Hengli supports the rapid advancement of drug candidates from early-stage research through to commercial manufacturing support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Hengli Medicine Science & Technology.